https://dub-signal.com/nuclear....-level-epitaxy-invol
RESULTS At 24 months, topics into the high-PP group (n = 7971) had comparable rates for the major end point (4.3% vs 3.9per cent; P = 0.058), POCE (14.9% vs 12.7%; P = 0.051), and BARC 3 or 5 (2.5% vs 1.7%; P = 0.355) and greater rates of NACE (16.4% vs 13.7per cent; P = 0.037) compared to the low-PP team (n = 7965). Among patients with PP less then 60 mm Hg, the main end-point (3.4% vs 4.4%, modified risk proportion [aHR] 0.77, 95% confidence interval [CI] 0.61-0.96), POCE (11.8% vs 13.5per cent, aHR 0
Like
Comment
Share
